银杏二萜内酯葡胺注射液治疗急性缺血性脑卒中的认知功能、神经营养因子、S100B蛋白及肝肾功能的影响

被引:7
作者
蒋炜丽
机构
[1] 徐州医科大学附属医院急救中心
关键词
银杏二萜内酯葡胺; 急性缺血性脑卒中; 认知功能; BDNF;
D O I
10.16281/j.cnki.jocml.2019.24.064
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
目的探讨银杏二萜内酯葡胺注射液治疗急性缺血性脑卒中的认知功能、神经营养因子、S100B蛋白及肝肾功能的影响。方法选取70例急性缺血性脑卒中患者,区组随机化分为2组,对照组采用常规治疗,观察组在此基础上静脉滴注银杏二萜内酯葡胺注射液,比较入组后14±2天两组患者认知功能,神经营养因子BDNF,S100B蛋白水平和肝肾功能。结果两组患者治疗前的认知功能评分,BDNF,S100B蛋白和肝肾功能均无显著性差异(P>0.05),经治疗后两组患者的MMSE评分,MoCA评分和BDNF均升高,且观察组显著高于对照组(P<0.05),两组患者的S100B蛋白均降低,且观察组降低程度高于对照组(P<0.05)。两组患者治疗前后肝肾功能无显著差异(P>0.05)。结论急性缺血性脑卒中患者加用银杏二萜内酯葡胺注射液治疗可以提高认知功能,改善神经影响因子BDNF和S100B蛋白水平,且对肝肾功能无严重影响。
引用
收藏
页码:81 / 83
页数:3
相关论文
共 17 条
  • [1] Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke:a randomised controlled trial. Li S,Zhang X,Fang Q,et al. . 2017
  • [2] 银杏酮酯分散片联合常规疗法治疗缺血性脑卒中临床观察
    王生寿
    王菊萍
    蔡清华
    [J]. 新中医, 2017, 49 (08) : 26 - 28
  • [3] 缺血性脑卒中患者应用阿托伐他汀联合阿司匹林的治疗效果分析
    黄俊杰
    尹小钢
    吴泽庆
    [J]. 中国医学创新, 2016, 13 (03) : 8 - 10
  • [4] 阿托伐他汀防治急性缺血性脑卒中的临床疗效观察
    黄卫华
    [J]. 临床医药实践, 2015, 24 (04) : 263 - 265
  • [5] Utility of Neuron-Specific enolase,in traumatic brain injure;relations to S100B levels,outcome,and extracranial injury severity. Thelin EP,Jeppsom E,et al. Journal of Critical Care . 2016
  • [6] Interferon-γpromotes neuronal repair by transplanted neural stem cells in ischemic rats. Zhang G,Guo X,Chen L,et al. Stem Cells and Development . 2018
  • [7] Investigation of UCH-L1 levels in ischemic stroke, intracranial hemorrhage and metabolic disorder induced impaired consciousness[J] . Ihsan Yigit,Metin Atescelik,Mustafa Yilmaz,Mehmet Cagri Goktekin,Mehtap Gurger,Nevin Ilhan. &nbspAmerican Journal of Emergency Medicine . 2017 (12)
  • [8] Atrial Fibrillation is Independently Associated with Cognitive Impairment after Ischemic Stroke
    Chander, Russell Jude
    Lim, Levinia
    Handa, Sagarika
    Hiu, Shaun
    Choong, Angeline
    Lin, Xuling
    Singh, Rajinder
    Oh, Daniel
    Kandiah, Nagaendran
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2017, 60 (03) : 867 - 875
  • [9] Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
    Chong, Zhao Zhong
    Changyaleket, Benjarat
    Xu, Haoliang
    Dull, Randy O.
    Schwartz, David E.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2016, 23 (15) : 1571 - 1596
  • [10] Decline in changing Montreal Cognitive Assessment (MoCA)scores is associated with poststroke cognitive decline determined by a formal neuropsychological evaluation. Tan HH,Xu J,Teoh HL,et al. PLoS One . 2017